about the author

Kyle LaHucik is an associate editor at Endpoints News, where he covers the people, partnerships, powder and pipelines behind the biopharma industry. His time on the beat began at Fierce Biotech, where he reported on financing, clinical trial results, management moves and the stories of LGBTQ+ leaders in life sciences. A graduate of the University of Missouri School of Journalism, Kyle has previously reported for Mergermarket, Bloomberg, the Columbia Missourian and other publications. He runs marathons, bikes along the Chicago lakefront and dabbles in bouldering outside of work hours.

author articles